Horus Scientific
Acquisition in 2024
Horus Scientific is a provider of histology and pathology services tailored for academic, governmental, industrial, and medical sectors. The company specializes in a range of immunohistochemistry services, employing both established and innovative methodologies. Horus Scientific collaborates closely with clients to ensure that their specific objectives are met, delivering customized solutions that cater to the unique needs of researchers, toxicologists, and medical professionals.
T3 Labs
Acquisition in 2023
T3 Labs is a provider of high-value pre-clinical testing and training services focused on medical devices and biologics. The company specializes in Good Laboratory Practice (GLP) compliant testing, ensuring that products meet regulatory standards before reaching the market. Additionally, T3 Labs offers comprehensive training services designed to enhance patient care by equipping physicians, sales staff, students, and allied healthcare professionals with essential knowledge and skills related to medical devices. By integrating testing and training, T3 Labs supports the healthcare community in delivering quality service tailored to their specific training needs.
Fusion Biotec
Acquisition in 2022
Fusion Biotec is a manufacturer of medical instruments focused on the diagnostics and medical device industry. The company specializes in developing custom medical devices and complex electro-mechanical diagnostic instrumentation. By integrating art, science, and engineering, Fusion Biotec aims to produce innovative and cost-effective medical gadgets that meet the needs of healthcare professionals. Their commitment to elegant and practical design allows them to create sophisticated products tailored to the evolving demands of the medical field.
Kickfile
Acquisition in 2022
Kickfile is a compliance technology company focused on the medical devices, cosmetics, and pharmaceutical sectors. The company aims to raise awareness and simplify the compliance process for innovative products entering the market. Kickfile provides essential tools, including processes, templates, and forms, to support clinical evaluation, clinical investigation, and post-market surveillance activities. By streamlining these critical compliance-related tasks, Kickfile facilitates the successful introduction and ongoing regulation of innovative devices and products.
Lea Reg
Acquisition in 2022
Lea Reg serves as a designated local representative or agent to help medical device and IVD companies meet national regulatory and registration requirements.
Devicia
Acquisition in 2022
Devicia is a full-service clinical research organization that specializes in medical devices and in vitro diagnostics. The company provides a comprehensive range of services, including medical writing, consultancy on strategy, quality assurance, regulatory affairs, clinical affairs, and biocompatibility. By leveraging a network of partner organizations, Devicia offers informed perspectives and robust support to clients throughout the entire life cycle of their medical devices, ensuring compliance and enhancing the development process.
Limulus Bio
Acquisition in 2022
Limulus Bio is a biocompatibility and toxicology partner for medical devices. It offers Internal and external education in biocompatibility and toxicology for medical devices, as well as conferences.
Clarvin
Acquisition in 2022
Clarvin is a healthcare consulting firm that specializes in regulatory affairs and quality assurance for medical devices. The company aims to shorten the time-to-market for new and innovative medical technologies by providing strategic guidance and informed execution throughout the regulatory process. Clarvin's services encompass various areas, including clinical trials, medical writing, regulatory strategies, toxicology assessments, and system technologies. By implementing efficient compliance strategies, Clarvin facilitates the global availability of medical devices, ensuring that they meet safety and regulatory standards before reaching patients.
Medidee
Acquisition in 2022
Medidee is a consultancy firm specializing in clinical and regulatory affairs for medical devices, aimed at supporting healthcare institutions in navigating compliance challenges. The company offers expertise in clinical research, medical data protection, and the regulatory frameworks of in vitro diagnostics and medical devices. Medidee assists clients in managing quality systems, ensuring their products are compliant with medical device regulations, and facilitating the transition to new regulatory requirements. By providing comprehensive health risk management services, Medidee enables clients to obtain the necessary approvals for their devices, allowing them to operate effectively within hospitals and clinics.
Worrell Design
Acquisition in 2021
Worrell Design is a design firm focused on healthcare innovation to create better health outcomes.
IMMR is a research is a contract research organization company that conducts and designs biotech and medtech preclinical surgical research. They excel in procedures ranging from early feasibility studies through to GLP studies to support worldwide regulatory approvals. In addition, the company has conferencing facilities and communications capabilities for interactive procedure observation, on-site and remote, real-time, and allowing virtual participation by additional members of your team and for training and demonstration purposes. IMMR was founded in 2003 and is headquartered in Paris, France.
Experien Group
Acquisition in 2021
Experien Group is a consulting firm that specializes in offering a comprehensive suite of regulatory, quality, and clinical services specifically tailored for MedTech companies. The company provides expertise in regulatory affairs, quality systems, and clinical processes, as well as pre-clinical and clinical consulting. Additionally, Experien Group offers data and biostatistics consulting to support its clients in navigating the complexities of the medical technology industry.
Ximedica
Acquisition in 2021
Ximedica has been a prominent player in the medical device industry for over 30 years, offering comprehensive research, development, regulatory, and manufacturing services. The company specializes in device and systems design, employing a human-centered, vertically integrated approach to enhance product efficiency from conception to market delivery. Ximedica's experienced, cross-disciplinary teams address complex development challenges, enabling clients to explore new market opportunities and achieve award-winning designs while exceeding sales targets. The firm emphasizes quality and regulatory assurance, underscored by its ISO 13485:2003 certification, which reflects its commitment to maintaining high standards in medical device innovation.
Boston Healthcare Associates
Acquisition in 2021
Boston Healthcare Associates is a global strategy consulting firm that specializes in advising clients on optimizing the value of innovations within the healthcare sector. The firm focuses on unlocking the potential of medical devices, diagnostics, and biopharmaceuticals, assisting both emerging and established companies in navigating the complexities of market access and value optimization. By developing tailored strategies, Boston Healthcare aims to support innovators in commercializing specialized products and services that can transform patient care and significantly enhance health outcomes in a rapidly changing healthcare landscape.
Quartesian
Acquisition in 2021
Quartesian is a pharmaceuticals company based in Princeton, New Jersey, specializing in clinical data management services. The company provides a range of offerings, including biostatistics, statistical programming, medical writing, pharmacovigilance, and data visualization. Quartesian aims to deliver customized and insightful data solutions to organizations conducting clinical studies, enabling them to effectively manage their data and enhance the clinical trial process. Through its comprehensive services, Quartesian supports clients in achieving their research and development goals within the pharmaceutical and biotechnology sectors.